Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery

Assessment Practices Registry in Congenital Cataract Surgery and Infantile

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02253017

Acronym

EP3C

Enrollment

Registered

2014-10-01

Start date

2014-09-30

Completion date

2015-12-31

Last updated

2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Therapeutic strategies, Pediatrics, Cataract, Surgery, Intra-ocular lens

Brief summary

The purpose of this observational study is to assess the therapeutic strategies in the treatment of pediatric cataracts.

Detailed description

Technical progress and recently described potential issues have recently challenged the surgical treatment of pediatric cataracts. Many questions remain unsolved: primary vs secondary implantation, nature of the implant used. The aim of this study is to establish a systematic prospective register of all cataracts operated on in a tertiary pediatric centre in order to help answering these questions.

Interventions

OTHERChildren operated on for cataract

Compilation of results of monitoring of children aged 8 to 10 months, 3 years, 5 years, 8 years

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

0 Years to 17 Years

Healthy volunteers

Inclusion criteria

* Child cataract surgery from 1 September 2014 in the Department of Ophthalmology, University Hospital Necker-Enfants Malades * Children aged between 0 and 17 years * Child with unilateral or bilateral cataract

Exclusion criteria

* Child with bilateral cataract, one eye having previously been operated in another center. * Children whose parents have notified the doctor their refusal of data collection

Design outcomes

Primary

Measure	Time frame	Description
Assessment practices in Pediatric Cataract Surgery.	8-10 months,	* Rating of efficacy of surgery depending on the implementation or not of a primary location * Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal) * Evaluation of effectiveness of surgery based on age (\<8 weeks of age for unilateral surgery and \<11 weeks of life for bilateral surgeries) * To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

Secondary

Measure	Time frame
Age at implantation	8-10 months,
Type of surgery and surgical procedures	8-10 months
Type of implant	8-10 months
Distance visual acuity	age of 8 years and 6 months after surgery if the child is carried out after the age of 8.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026